Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argininosuccinate lyase pseudogene 1 (ASLP1) is a non-functional genomic sequence related to the argininosuccinate lyase gene. Unlike the functional **ASL** gene, which encodes an enzyme critical for the urea cycle and ammonia detoxification[1][2], **ASLP1** is a pseudogene with no protein product, biological function, or direct implications in disease or therapy. It is found on chromosome 22 as a nontranscribed pseudogene[2]. Note that all key biological information, druggability, and disease associations pertain to the functional ASL gene, not its pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate lyase pseudogene 1 (ASLP1).